Ładuje się......
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Chinês |
| Wydane: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| Seria: | Chinese Journal of Lung Cancer |
| Hasła przedmiotowe: | |
| Dostęp online: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|